Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine dose-ranging with sufentanil for PCIA after laparoscopic hysterectomy
ChiCTR2000035409Phase 4Recruiting
- Sponsor
- Department of Anesthesiology, Second Affiliated Hospital of Nanjing Medical University
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine and sufentanil in postoperative pain (4 arms), sponsored by Department of Anesthesiology, Second Affiliated Hospital of Nanjing Medical University. Primary endpoints: VAS score, Total PCIA presses and supplementary analgesia and 1 more. Started Jul 2020; status: recruiting.
02
Drugs
nalbuphinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2000035409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035409.